Accelerated mammary tumor onset in a HER2/neu mouse model exposed to DDT metabolites locally delivered to the mammary gland

Environmental Health Perspectives

Volumn 120, Issue 8, 2012, Pages 1170-1176

  Johnson, Nakpangi A ^a   Ho, Arline ^b   Mark Cline, J ^c   Hughes, Claude L ^b,d   Foster, Warren G ^b,e   Davis, Vicki L ^a,b,f  

^a DUQUESNE UNIVERSITY   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c WAKE FOREST BAPTIST HEALTH   (United States)

^d IQVIA   (United States)

^e MCMASTER UNIVERSITY   (Canada)

^f CLARION UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Antiandrogen; Breast cancer; DDT; Endocrine disruptor; HER2 neu; O,P' DDE; P,P' DDE

Indexed keywords

1, 1 DICHLORO 2, 2 BIS (4 CHLOROPHENYL) ETHYLENE; EPIDERMAL GROWTH FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST EPITHELIUM; BREAST TUMOR; CANCER INCIDENCE; CARCINOGENESIS; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; MASS FRAGMENTOGRAPHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; DDT; DISEASE MODELS, ANIMAL; GENES, ERBB-2; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE;

ANIMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS;

EID: 84864752408     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.1104327     Document Type: Article

References (41)

1. Andersen HR, Andersson AM, Arnold SF, Autrup H, Barfoed M, Beresford NA, et al. 1999. Comparison of short-term estrogenicity tests for identification of hormone-disrupting chemicals. Environ Health Perspect 107(suppl 1):89-108.
2. Benz CC. 2008. Impact of aging on the biology of breast cancer. Crit Rev Oncol Hematol 66:65-74.
3. Bernert JT, Turner WE, Patterson DG Jr, Needham LL. 2007. Calculation of serum "total lipid" concentrations for the adjustment of persistent organohalogen toxicant measurements in human samples. Chemosphere 68:824-831.
4. Cabanes A, Wang M, Olivo S, DeAssis S, Gustafsson J-A, Khan G, et al. 2004. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis. Carcinogenesis 25:741-748.
5. Cato AC, Henderson D, Ponta H. 1987. The hormone response element of the mouse mammary tumour virus DNA mediates the progestin and androgen induction of transcription in the proviral long terminal repeat region. EMBO J 6:363-368.
6. Charlier C, Foidart J-M, Pitance F, Herman P, Gaspard U, Meurisse M, et al. 2004. Environmental dichlorodiphenyltrichlorethane or hexachlorobenzene exposure and breast cancer: is there a risk? Clin Chem Lab Med 42:222-227.
7. Cohn BA. 2011. Developmental and environmental origins of breast cancer: DDT as a case study. Reprod Toxicol 31:302-311.
8. Cohn BA, Wolff MS, Cirillo PM, Sholtz RI. 2007. DDT and breast cancer in young women: new data on the significance of age at exposure. Environ Health Perspect 115:1406-1414.
9. Davis VL, Jayo MJ, Ho A, Kotlarczyk MP, Hardy ML, Foster WG, et al. 2008. Black cohosh increases metastatic mammary cancer in transgenic mice expressing c-erbB2. Cancer Res 68:8377-8383.
10. Demers A, Ayotte P, Brisson J, Dodin S, Robert J, Dewailly E. 2000. Risk and aggressiveness of breast cancer in relation to plasma organochlorine concentrations. Cancer Epidemiol Biomarkers Prev 9:161-166.
11. Dimitrakakis C, Zhou J, Wang J, Belanger A, LaBrie F, Cheng C, et al. 2003. A physiologic role for testosterone in limiting estrogenic stimulation of the breast. Menopause 10:292-298.
12. Dorgan JF, Brock JW, Rothman N, Needham LL, Miller R, Stephenson HE Jr, et al. 1999. Serum organochlorine pesticides and PCBs and breast cancer risk: results from a prospective analysis (USA). Cancer Causes Control 10:1-11.
13. Eskenazi B, Chevrier J, Rosas LG, Anderson HA, Bornman MS, Bouwman H, et al. 2009. The Pine River statement: human health consequences of DDT use. Environ Health Perspect 117:1359-1367.
14. Falck F Jr, Ricci A Jr, Wolff MS, Godbold J, Deckers P. 1992. Pesticides and polychlorinated biphenyl residues in human breast lipids and their relation to breast cancer. Arch Environ Health 47:143-146.
15. Fenton SE. 2006. Endocrine-disrupting compounds and mammary gland development: early exposure and later life consequences. Endocrinology 147:S18-S24.
16. Foster W, Chan S, Platt L, Hughes C. 2000. Detection of endocrine disrupting chemicals in samples of second trimester human amniotic fluid. J Clin Endocrinol Metab 85:2954-2957.
17. Gammon MD, Wolff MS, Neugut AI, Eng SM, Teitelbaum SL, Britton JA, et al. 2002. Environmental toxins and breast cancer on Long Island. II. Organochlorine compound levels in blood. Cancer Epidemiol Biomarkers Prev 11:686-697.
18. Gatto NM, Longnecker MP, Press MF, Sullivan-Halley J, McKean-Cowdin R, Bernstein L. 2007. Serum organochlorines and breast cancer: a case-control study among African-American women. Cancer Causes Control 18:29-39.
19. Guttes S, Failing K, Neumann K, Kleinstein J, Georgii S, Brunn H. 1998. Chlororganic pesticides and polychlorinated biphenyls in breast tissue of women with benign and malignant breast disease. Arch Environ Contam Toxicol 35:140-147.
20. Guy CT, Webster MA, Schaller M, Parsons TJ, Cardiff RD, Muller WJ. 1992. Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease. Proc Natl Acad Sci USA 89:10578-10582.
21. Haslam SZ. 1988. Local versus systemically mediated effects of estrogen on normal mammary epithelial cell deoxyribonucleic acid synthesis. Endocrinology 122:860-867.
22. Kelce WR, Stone CR, Laws SC, Gray LE, Kemppainen JA, Wilson EM. 1995. Persistent DDT metabolite p,p'-DDE is a potent androgen receptor antagonist. Nature 375:581-585.
23. Laden F, Collman G, Iwamoto K, Alberg AJ, Berkowitz GS, Freudenheim JL, et al. 2001. 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls and breast cancer: combined analysis of five U.S. studies. J Natl Cancer Inst 93:768-776.
24. Liao DJ, Dickson RB. 2002. Roles of androgens in the development, growth, and carcinogenesis of the mammary gland. J Steroid Biochem Mol Biol 80:175-189.
25. Lopez-Carrillo L, Torres-Sanchez L, Lopez-Cervantes M, Blair A, Cebrian ME, Uribe M. 1999. The adipose tissue to serum dichlorodiphenyldichloroethane (DDE) ratio: some methodological considerations. Environ Res 81:142-145.
26. Lopez-Cervantes M, Torres-Sanchez L, Tobias A, Lopez-Carrillo L. 2004. Dichlorodiphenyldichloroethane burden and breast cancer risk: a meta-analysis of the epidemiologic evidence. Environ Health Perspect 112:207-214.
27. Menard S, Aiello P, Tagliabue E, Rumio C, Lollini PL, Colnaghi MI, et al. 2000. Tamoxifen chemoprevention of a hormone-independent tumor in the proto-neu transgenic mice model. Cancer Res 60:273-275.
28. Millikan R, DeVoto E, Duell EJ, Tse CK, Savitz DA, Beach J, et al. 2000. Dichlorodiphenyldichloroethene, polychlorinated biphenyls, and breast cancer among African-American and white women in North Carolina. Cancer Epidemiol Biomarkers Prev 9:1233-1240.
29. Muhlebach S, Moor MJ, Wyss PA, Bickel MH. 1991. Kinetics of distribution and elimination of DDE in rats. Xenobiotica 21:111-120.
30. Newman LA. 2005. Breast cancer in African-American women. Oncologist 10:1-14.
31. Ociepa-Zawal M, Rubis B, Wawrzynczak D, Wachowiak R, Trzeciak WH. 2010. Accumulation of environmental estrogens in adipose tissue of breast cancer patients. J Environ Sci Health Part A Tox Hazard Subst Environ Eng 45:305-312.
32. Payne J, Scholze M, Kortenkamp A. 2001. Mixtures of four organochlorines enhance human breast cancer cell proliferation. Environ Health Perspect 109:391-397.
33. Shakeel MK, George PS, Jose J, Jose J, Mathew A. 2010. Pesticides and breast cancer risk: a comparison between developed and developing countries. Asian Pac J Cancer Prev 11:173-180.
34. Silberstein GB, Daniel CW. 1982. Elvax 40P implants: sustained, local release of bioactive molecules influencing mammary ductal development. Dev Biol 93:272-278.
35. Snedeker SM. 2001. Pesticides and breast cancer risk: a review of DDT, DDE, and dieldrin. Environ Health Perspect 109 Suppl 1:35-47.
36. Somboonporn W, Davis SR. 2004. Testosterone effects on the breast: implications for testosterone therapy for women. Endocr Rev 25:374-388.
37. Vetto JT, Luoh SW, Naik A. 2009. Breast cancer in premenopausal women. Curr Probl Surg 46:944-1004.
38. Wolff MS, Berkowitz GS, Brower S, Senie R, Bleiweiss IJ, Tartter P, et al. 2000a. Organochlorine exposures and breast cancer risk in New York City women. Environ Res 84:151-161.
39. Wolff MS, Britton JA, Teitelbaum SL, Eng S, Deych E, Ireland K, et al. 2005. Improving organochlorine biomarker models for cancer research. Cancer Epidemiol Biomarkers Prev 14:2224-2236.
40. Wolff MS, Zeleniuch-Jacquotte A, Dubin N, Toniolo P. 2000b. Risk of breast cancer and organochlorine exposure. Cancer Epidemiol Biomarkers Prev 9:271-277.
41. Yeh S, Hu Y-C, Wang P-H, Xie C, Xu Q, Tsai M-Y, et al. 2003. Abnormal mammary gland development and growth retardation in female mice and MCF7 breast cancer cells lacking androgen receptor. J Exp Med 198:1899-1908.